navoximod

URI: https://gptkb.org/entity/navoximod
GPTKB entity
Statements (13)
Predicate Object
gptkbp:instanceOf gptkb:chemical_compound
gptkb:indoleamine_2,3-dioxygenase_inhibitor
gptkbp:CASNumber 1204669-58-8
gptkbp:clinicalTrialPhase gptkb:Phase_I
gptkbp:developedBy gptkb:Genentech
gptkbp:hasMolecularFormula C17H14ClN3O3
gptkbp:intendedUse gptkb:immunotherapy
gptkbp:mechanismOfAction IDO1 inhibitor
gptkbp:routeOfAdministration oral
gptkbp:synonym gptkb:GDC-0919
gptkbp:bfsParent gptkb:IDO1
gptkbp:bfsLayer 7
https://www.w3.org/2000/01/rdf-schema#label navoximod